Anne Pradines Selected Research

Anne Pradines Research Topics

Disease

18	Neoplasms (Cancer) 11/2022 - 04/2004
12	Lung Neoplasms (Lung Cancer) 01/2023 - 04/2004
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 12/2014
5	Melanoma (Melanoma, Malignant) 11/2022 - 06/2015
4	Carcinogenesis 01/2017 - 04/2004
3	Breast Neoplasms (Breast Cancer) 11/2022 - 01/2022
3	Circulating Neoplastic Cells 01/2018 - 01/2016
3	Adenocarcinoma of Lung 01/2017 - 01/2016
2	Disease Progression 11/2022 - 12/2020
2	Residual Neoplasm 07/2021 - 03/2020
2	Hypersensitivity (Allergy) 06/2015 - 01/2014
1	Neoplasm Metastasis (Metastasis) 11/2022
1	Lymphopenia (Lymphocytopenia) 11/2022
1	Fatigue 11/2022
1	Neutropenia 11/2022
1	Lymphoma (Lymphomas) 01/2021
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 05/2017
1	Adenocarcinoma 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Osteosarcoma (Osteogenic Sarcoma) 05/2006
1	Carcinoma (Carcinomatosis) 04/2004

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 11/2019 - 12/2014
5	Circulating Tumor DNAIBA 10/2021 - 01/2016
3	Cell-Free Nucleic AcidsIBA 01/2023 - 10/2016
3	palbociclibIBA 11/2022 - 01/2022
3	Aromatase InhibitorsIBA 11/2022 - 01/2022
3	Tyrosine Kinase InhibitorsIBA 05/2022 - 01/2017
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2022 - 06/2015
3	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2016
3	Monomeric GTP-Binding ProteinsIBA 01/2018 - 01/2017
2	GTP Phosphohydrolases (GTPases)IBA 01/2019 - 01/2017
2	TransferasesIBA 11/2007 - 04/2004
1	Fulvestrant (Faslodex)FDA Link 11/2022
1	Letrozole (Femara)FDA LinkGeneric 11/2022
1	Anastrozole (Arimidex)FDA LinkGeneric 11/2022
1	exemestane (Aromasin)FDA Link 11/2022
1	ErbB Receptors (EGF Receptor)IBA 05/2022
1	dabrafenibIBA 02/2022
1	trametinibIBA 02/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 11/2019
1	AntibodiesIBA 02/2019
1	Serine (L-Serine)FDA Link 01/2018
1	NivolumabIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Threonine (L-Threonine)FDA Link 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Tumor Biomarkers (Tumor Markers)IBA 05/2017
1	Genetic Markers (Genetic Marker)IBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Circulating MicroRNAIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 06/2015
1	VemurafenibIBA 06/2015
1	Small Interfering RNA (siRNA)IBA 01/2014
1	Histones (Histone)IBA 01/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2009
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 02/2008
1	Histone Deacetylase InhibitorsIBA 11/2007
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2007
1	hydrogen sulfite (bisulfite)IBA 11/2007
1	Proteins (Proteins, Gene)FDA Link 05/2006
1	NF-kappa B (NF-kB)IBA 04/2005
1	rhoB GTP-Binding ProteinIBA 04/2004

Therapy/Procedure

11	Therapeutics 11/2022 - 04/2004
3	Immunotherapy 07/2021 - 02/2019
2	Drug Therapy (Chemotherapy) 07/2021 - 04/2004
1	Adjuvant Chemotherapy 07/2021
1	Precision Medicine 10/2016
1	Radiotherapy 04/2004